MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells
2023 · Cell Reports · 5 citations
https://doi.org/10.1016/j.celrep.2023.112484
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
5
Citations
1
h-index
0
i10-index
Anabel Zelceski is an academic researcher from Institute of Cancer Research. The author has contributed to research in topics: DNA Repair Mechanisms & PARP inhibition in cancer therapy & Cell death mechanisms and regulation. The author has an h-index of 1, co-authored 2 publications.
ORCID: 0000-0001-6437-6072Click to start Chat